Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 22,095,973	$ 18,870,510	$ 16,537,433
Cost of goods sold	14,355,869	12,236,374	10,882,592
Gross profit	7,740,104	6,634,136	5,654,841
Operating expenses:
Selling, administrative and other expenses	5,758,295	5,162,506	4,386,739
Depreciation and amortization	347,819	290,971	272,842
Provision for doubtful accounts	19,791	17,739	23,577
Restructuring costs	0	0	50,019
Goodwill impairment charge	0	0	506,721
Total operating expenses	6,125,905	5,471,216	5,239,898
Non-operating expenses (income):
Interest expense, net	73,887	62,150	91,048
Other	(32,290)	(99,576)	(55,473)
Total non-operating expenses (income)	41,597	(37,426)	35,575
Income before income taxes	1,572,602	1,200,346	379,368
Income taxes	389,901	301,556	215,973
Net income from continuing operations	1,182,701	898,790	163,395
Net loss from discontinued operations	0	0	(192,497)
Net income (loss)	$ 1,182,701	$ 898,790	$ (29,102)
Basic earnings (loss) per share:
Continuing operations (in dollars per share)	$ 8.36	$ 6.27	$ 1.13
Discontinued operations (in dollars per share)	0	0	(1.33)
Basic earnings (loss) per share (in dollars per share)	8.36	6.27	(0.20)
Diluted earnings (loss) per share:
Continuing operations (in dollars per share)	8.31	6.23	1.13
Discontinued operations (in dollars per share)	0	0	(1.33)
Diluted earnings (loss) per share (in dollars per share)	$ 8.31	$ 6.23	$ (0.20)
Weighted average common shares outstanding (in shares)	141,468	143,435	144,474
Dilutive effect of stock options and nonvested restricted stock awards (in shares)	854	786	641
Weighted average common shares outstanding — assuming dilution (in shares)	142,322	144,221	145,115